Intercept Pharmaceuticals (ICPT) PT Lowered to $240 at Citi
Tweet Send to a Friend
Citi lowered its price target on Intercept Pharmaceuticals (NASDAQ: ICPT) to $240.00 (from $275.00) while maintaining a Buy rating.Dr. Joel ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
